Annual report pursuant to Section 13 and 15(d)

SHAREHOLDERS' EQUITY - Narrative (Details)

v3.23.1
SHAREHOLDERS' EQUITY - Narrative (Details)
 1 Months Ended 12 Months Ended
Mar. 04, 2023
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Nov. 15, 2021
USD ($)
$ / shares
shares
Apr. 30, 2021
USD ($)
shares
Jun. 30, 2021
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Mar. 03, 2023
$ / shares
shares
Oct. 11, 2022
$ / shares
Mar. 03, 2022
shares
Jun. 09, 2021
shares
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                    
Common stock, shares authorized   9,000,000       9,000,000        
Common stock, par value (in dollars per share) | $ / shares   $ 0.001       $ 0.001   $ 0.001    
Common stock, shares issued   1,051,098       645,943     22,021,952  
Common stock, shares outstanding   1,051,098       645,943     22,021,952  
Reverse stock split ratio 0.05                  
Fractional shares issued 0                  
Shares issued     909,262   7,802          
Share price | $ / shares     $ 123.80   $ 80.00          
Shares issue price | $ / shares     $ 105.00              
Common share purchase warrants per unit                   1
Term of warrants                   48 months
Proceeds from Issuance of Private Placement | $     $ 4,750,000              
Value of shares issued on settlement of employee compensation | $     $ 435,000              
Outstanding principal | $           $ 60,000        
Shares issued on conversion of debt           669        
Subsequent Events                    
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                    
Common stock, shares authorized 9,000,000           180,000,000      
Common stock, par value (in dollars per share) | $ / shares $ 0.001           $ 0.001      
Reverse stock split ratio 0.05                  
Fractional shares issued 0                  
Amended Stock Option Plan                    
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                    
Common stock, shares outstanding   42,540                
Equity Incentive Plan                    
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                    
Common stock, shares outstanding   6,500                
Number of shares authorized   93,500                
NervePro                    
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                    
Share issuance, acquisition related (in shares)   75,000                
Intangible asset | $   $ 390,000                
Sentry Neuromonitoring, LLC                    
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                    
Value of common stock issuable | $       $ 1,625,000            
Common stock issuable       11,861            
Held in escrow, Value | $       $ 650,000            
Held in escrow, Shares       4,745            
Common stock lock up period       12 months